Xenoport is focused on developing therapeutics that harness the body’s intrinsic transport systems to improve the oral absorption, distribution and pharmacokinetics of drugs.

Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient and effective platform for drug design and development.

Triangle Pharmaceuticals provided anti-viral and oncology licensing.

Sunesis Pharmaceuticals discovers and develops novel small molecule therapeutics for important diseases, with a primary focus on the regulation of protein-protein and small molecule-protein interactions as well as other enzymes.

SUGEN developed novel therapeutics through receptor-based approaches to drug discovery, primarily involving kinases and phosphatases.

Signal Pharmaceuticals developed new classes of drugs that regulate genes associated with disease.

Renovis is a biopharmaceutical company focusing on neurological and psychiatric diseases and disorders, using a combination of novel genomics and cell-based assay technologies.